Page last updated: 2024-08-24

epigallocatechin gallate and Ewing Sarcoma

epigallocatechin gallate has been researched along with Ewing Sarcoma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jenabi, JM; Kang, HG; Liu, XF; Reynolds, CP; Sorensen, PH; Triche, TJ	1
Ivanov, V; Kalinovsky, T; Niedzwiecki, A; Rath, M; Roomi, MW	1

Other Studies

2 other study(ies) available for epigallocatechin gallate and Ewing Sarcoma

Article	Year
Inhibition of the insulin-like growth factor I receptor by epigallocatechin gallate blocks proliferation and induces the death of Ewing tumor cells. Molecular cancer therapeutics, 2010, Volume: 9, Issue:5 Topics: Anticarcinogenic Agents; Apoptosis; Bone Neoplasms; Catechin; Cell Adhesion; Cell Death; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Drug Evaluation, Preclinical; Humans; MAP Kinase Signaling System; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Phosphorylation; Receptor, IGF Type 1; Sarcoma, Ewing	2010
Antitumor effect of nutrient synergy on human osteosarcoma cells U-2OS, MNNG-HOS and Ewing's sarcoma SK-ES.1. Oncology reports, 2005, Volume: 13, Issue:2 Topics: Arginine; Ascorbic Acid; Bone Neoplasms; Catechin; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Lysine; Matrix Metalloproteinases; Neovascularization, Pathologic; Nutritional Physiological Phenomena; Osteosarcoma; Proline; Sarcoma, Ewing; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A	2005

Article

Year

Inhibition of the insulin-like growth factor I receptor by epigallocatechin gallate blocks proliferation and induces the death of Ewing tumor cells.

Molecular cancer therapeutics, 2010, Volume: 9, Issue:5

Topics: Anticarcinogenic Agents; Apoptosis; Bone Neoplasms; Catechin; Cell Adhesion; Cell Death; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Drug Evaluation, Preclinical; Humans; MAP Kinase Signaling System; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Phosphorylation; Receptor, IGF Type 1; Sarcoma, Ewing

2010

Antitumor effect of nutrient synergy on human osteosarcoma cells U-2OS, MNNG-HOS and Ewing's sarcoma SK-ES.1.

Oncology reports, 2005, Volume: 13, Issue:2

Topics: Arginine; Ascorbic Acid; Bone Neoplasms; Catechin; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Lysine; Matrix Metalloproteinases; Neovascularization, Pathologic; Nutritional Physiological Phenomena; Osteosarcoma; Proline; Sarcoma, Ewing; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A

2005